| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2023-02-21 17:15:37 UTC |
|---|
| HMDB ID | HMDB0001352 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Hydroxypyruvic acid |
|---|
| Description | Hydroxypyruvic acid, also known as 3-hydroxypyruvate or OH-pyr, belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. Hydroxypyruvic acid is an extremely weak basic (essentially neutral) compound (based on its pKa). Hydroxypyruvic acid exists in all living organisms, ranging from bacteria to humans. hydroxypyruvic acid and L-alanine can be biosynthesized from pyruvic acid and L-serine; which is mediated by the enzyme serine--pyruvate aminotransferase. In humans, hydroxypyruvic acid is involved in the metabolic disorder called the dimethylglycine dehydrogenase deficiency pathway. Outside of the human body, Hydroxypyruvic acid has been detected, but not quantified in, several different foods, such as elderberries, summer savories, fireweeds, garland chrysanthemums, and shiitakes. This could make hydroxypyruvic acid a potential biomarker for the consumption of these foods. |
|---|
| Structure | InChI=1S/C3H4O4/c4-1-2(5)3(6)7/h4H,1H2,(H,6,7) |
|---|
| Synonyms | | Value | Source |
|---|
| 3-Hydroxypyruvate | Kegg | | 3-Hydroxypyruvic acid | Kegg | | Hydroxypyruvate | Generator | | 3-Hydroxy-2-oxopropanoate | HMDB | | 3-Hydroxy-2-oxopropanoic acid | HMDB | | beta-Hydroxypyruvate | HMDB | | OH-Pyr | HMDB | | OH-Pyruvate | HMDB | | 2-Oxo-3-hydroxypropanoic acid | HMDB | | 2-Oxo-3-hydroxypropionic acid | HMDB | | 3-Hydroxy-2-oxopropionic acid | HMDB | | Hydroxypyruvic acid | HMDB | | beta-Hydroxypyruvic acid | HMDB | | β-Hydroxypyruvic acid | HMDB |
|
|---|
| Chemical Formula | C3H4O4 |
|---|
| Average Molecular Weight | 104.0615 |
|---|
| Monoisotopic Molecular Weight | 104.010958616 |
|---|
| IUPAC Name | 3-hydroxy-2-oxopropanoic acid |
|---|
| Traditional Name | hydroxypyruvic acid |
|---|
| CAS Registry Number | 1113-60-6 |
|---|
| SMILES | OCC(=O)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C3H4O4/c4-1-2(5)3(6)7/h4H,1H2,(H,6,7) |
|---|
| InChI Key | HHDDCCUIIUWNGJ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Hydroxy acids and derivatives |
|---|
| Sub Class | Beta hydroxy acids and derivatives |
|---|
| Direct Parent | Beta hydroxy acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Beta-hydroxy acid
- Alpha-keto acid
- Keto acid
- Monosaccharide
- Alpha-hydroxy ketone
- Ketone
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organooxygen compound
- Alcohol
- Carbonyl group
- Organic oxygen compound
- Primary alcohol
- Hydrocarbon derivative
- Organic oxide
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.43 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.2255 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.58 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 213.6 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 793.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 368.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 77.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 261.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 92.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 273.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 281.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 599.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 606.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 60.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 831.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 233.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 291.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 711.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 313.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 342.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Hydroxypyruvic acid,1TMS,isomer #1 | C[Si](C)(C)OCC(=O)C(=O)O | 1143.6 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)C(=O)CO | 1064.0 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,1TMS,isomer #3 | C[Si](C)(C)OC(=CO)C(=O)O | 1201.0 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,2TMS,isomer #1 | C[Si](C)(C)OCC(=O)C(=O)O[Si](C)(C)C | 1292.9 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,2TMS,isomer #2 | C[Si](C)(C)OC=C(O[Si](C)(C)C)C(=O)O | 1315.1 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,2TMS,isomer #3 | C[Si](C)(C)OC(=O)C(=CO)O[Si](C)(C)C | 1228.3 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,3TMS,isomer #1 | C[Si](C)(C)OC=C(O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1396.4 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,3TMS,isomer #1 | C[Si](C)(C)OC=C(O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1305.1 | Standard non polar | 33892256 | | Hydroxypyruvic acid,3TMS,isomer #1 | C[Si](C)(C)OC=C(O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1352.9 | Standard polar | 33892256 | | Hydroxypyruvic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)C(=O)O | 1418.9 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(=O)CO | 1334.7 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=CO)C(=O)O | 1434.3 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OCC(=O)C(=O)O[Si](C)(C)C(C)(C)C | 1710.0 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)C(=O)O | 1788.5 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)C(=CO)O[Si](C)(C)C(C)(C)C | 1730.1 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1999.0 | Semi standard non polar | 33892256 | | Hydroxypyruvic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1886.9 | Standard non polar | 33892256 | | Hydroxypyruvic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC=C(O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1784.9 | Standard polar | 33892256 |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|